Status:
COMPLETED
Predict Adverse Events by Covid-19 Nephritis
Lead Sponsor:
University Hospital Goettingen
Collaborating Sponsors:
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Aachen
Conditions:
Covid-19
Eligibility:
All Genders
Brief Summary
This non-interventional, observational study retrospectively (and in parts prospectively) investigates, if a Covid-19 associated Nephritis, diagnosed by Urine-dipstick and further Urine-analyses on ad...
Detailed Description
Parameters predicting risks for Covid-19 patients are urgently sought. The current study investigates, if Covid-19 associated nephritis indicating systemic cappillary leak syndrome/severe nephrotic sy...
Eligibility Criteria
Inclusion
- approved Covid-19 diagnosis (by PCR or CT-scan);
- urine status during hospital stay
- Patient expressed willingness to participate in observational studies during hospital admission.
Exclusion
- 1\) Patient expressed unwillingness to participate in observational studies during hospital admission.
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
223 Patients enrolled
Trial Details
Trial ID
NCT04347824
Start Date
April 27 2020
End Date
March 31 2021
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center Goettingen
Göttingen, Germany